Analogic Corporation (NASDAQ: ALOG) and Novadaq Technologies (NASDAQ:NVDQ) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.
Volatility and Risk
Analogic Corporation has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Novadaq Technologies has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500.
Insider and Institutional Ownership
86.5% of Novadaq Technologies shares are held by institutional investors. 1.2% of Analogic Corporation shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Dividends
Analogic Corporation pays an annual dividend of $0.40 per share and has a dividend yield of 0.6%. Novadaq Technologies does not pay a dividend. Analogic Corporation pays out -12.2% of its earnings in the form of a dividend.
Analyst Ratings
This is a breakdown of current recommendations for Analogic Corporation and Novadaq Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Analogic Corporation | 0 | 3 | 1 | 0 | 2.25 |
| Novadaq Technologies | 0 | 11 | 2 | 0 | 2.15 |
Analogic Corporation presently has a consensus target price of $87.00, indicating a potential upside of 24.29%. Novadaq Technologies has a consensus target price of $11.86, indicating a potential upside of 2.48%. Given Analogic Corporation’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Analogic Corporation is more favorable than Novadaq Technologies.
Profitability
This table compares Analogic Corporation and Novadaq Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Analogic Corporation | -7.97% | 6.75% | 5.73% |
| Novadaq Technologies | -66.61% | -49.07% | -39.91% |
Earnings & Valuation
This table compares Analogic Corporation and Novadaq Technologies’ gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| Analogic Corporation | $512.87 million | 1.70 | $65.24 million | ($3.29) | -21.28 |
| Novadaq Technologies | $83.87 million | 7.98 | -$46.77 million | ($0.96) | -12.05 |
Analogic Corporation has higher revenue and earnings than Novadaq Technologies. Analogic Corporation is trading at a lower price-to-earnings ratio than Novadaq Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Analogic Corporation beats Novadaq Technologies on 11 of the 15 factors compared between the two stocks.
About Analogic Corporation
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.
About Novadaq Technologies
NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company’s SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.
Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
